Network pharmacology and molecular docking of endogenous active metabolites in diabetic kidney disease

Network pharmacology and molecular docking of endogenous active metabolites in diabetic kidney disease

AbstractObjectives Network pharmacology and molecular docking were used to predict endogenous active metabolites with protective effects in diabetic kidney disease (DKD).Methods We utilized metabolomics to screen differentially expressed metabolites in kidney tissues of mice with type 2 DKD and pred...

Full description

Bibliographic Details
Main Authors: Xinmiao Xie, Yanzhe Wang, Sijia Chen, Yuyuan Liu, Fengqin Li, Chuchu Zeng, Ling Zhang, Xiaoxia Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
DKD
endogenous active metabolites
network pharmacology
2-hydroxyphenyl­propionylglycine
SYNJ1
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2290927

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2023.2290927

Similar Items